Iodinated cholylglycyltyrosine: A new agent for hepatobiliary imaging
Tóm tắt
The characteristics of radiolabelled cholylglycyl-tyrosine (CGT), a recently synthesised bile acid, were studied. 125I-CGT-Na was found to have a short plasma half-life of 1.6±0.4 min in rats and 3.1±0.7 min in dogs. Biliary clearance studies showed the cumulative biliary output of the tracer over 20 min in rats to be 95.7% of the total dose administered, with a mean biliary transit time (50% retention time) of 4.0±0.1 min, i.e. similar to the biliary kinetics of taurocholate. 131I-CGT-Na proved to be satisfactory for hepatobiliary imaging in rats and dogs at doses of 35 μCi (1.3 MBq) in rats and 90 μCi (3.3 MBq) in dogs. Satisfactory hepatic images were also obtained in rats that had high bilirubin levels produced by obstruction or the recycling of bile. These results show that CGT has better pharmacokinetics than currently used hepatobiliary imaging agents, and that this new compound may be useful in scintigraphy even in the presence of jaundice.
Tài liệu tham khảo
Clements D, Iqbal S, Mills C, Elias E (1985) A new method of complete biliary retention. Lab Anim 19:277–278
Fritzberg AR, Klingensmith WC (1982) Quest for the perfect hepatobiliary radiopharmaceutical. J Nucl Med 23:543–546
Hardison WGM, Weiner RG, Hatoff DE, Miyai K (1983) Similarities and differences between models of extrahepatic biliary obstruction and complete biliary retention without obstruction in the rat. Hepatology 3:383–390
Harvey E, Loberg M, Cooper M (1975) A new radiopharmaceutical for hepatobiliary imaging. J Nucl Med 16:533
Harvey E, Loberg M, Ryan J, Sikorski S, Faith W, Cooper M (1979) Hepatic clearance mechanism of Tc-99m-HIDA and its effect on quantitation of hepatobiliary function: Concise communication. J Nucl Med 20:310–313
Jenkins SA, Grandison A, Baxter JN, Day DW, Taylor I, Shields R (1985) A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J Hepatol (in press)
Loberg MD, Cooper M, Harvey E, Callery P, Faith W (1976) Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J Nucl Med 17:633–638
Madden JW, Gertman PM, Peacock EE Jr (1970) Dimethylnitrosamine-induced hepatic cirrhosis: A new canine model of an ancient human disease. Surgery 68:260–268
Merrick MV, Eastwood MA, Anderson JR, Ross HM (1982) Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT). J Nucl Med 23:126–130
Mills CO, Iqbal S, Elias E (1984) Synthesis and biliary output of novel bile acids with a tyrosine moiety. Proceedings of the International Association for the Study of the Liver, Berne, Switzerland, 3–4 September. Falk Foundation, Freiburg-imBreisgau, p 67
Oster-Jorgensen E, Pedersen SA, Schoubye J (1979) Hepatobiliary scintigraphy with 99mTc-HIDA in patients with jaundice. Acta Radiol [Diagn] (Stockh) 20:299–310
Pauwels S, Steels M, Piret L, Beckers C (1978) Clinical evaluation of Tc-99m-diethyl-IDA in hepatobiliary disorders. J Nucl Med 19:783–788
Rosenthall L, Shaffer EA, Lisbona R, Pare P (1978) Diagnosis of hepatobiliary disease by 99mTc-HIDA cholescintigraphy. Radiology 126:467–474
Ryan J, Cooper M, Loberg M, Harvey E, Sikorski S (1977) Technetium-99m-labelled N-(2.6-dimethylphenylcarboxylmethyl) iminodiacetic acid (Tc-99m HIDA): a new radiopharmaceutical for hepatobiliary imaging studies. J Nucl Med 18:997–1004
Smith RB, Coupal J, De Land FH, Triplett JW (1979) Pharmacokinetics of hepatobiliary imaging agents in rats. Concise communication. J Nucl Med 20:45–49
Spenney JG, Johnson BJ, Hirschowitz BI, Mihas AA, Gibson R (1977) An 125I-Radioimmunoassay for primary conjugated bile salts. Gastroenterology 72:305–311
Spenney JG, Tobin MM, Mihas AA, Gibson RG, Hirschowitz BI, Johnson BJ, Tauxe WN (1979) Utilization of a radioiodinated bile salt for kinetic studies and hepatic scintigraphy. Gastroenterology 76:272–278
Taplin GV, Meredith OM, Kade H (1955) The radioactive I-131-tagged rose bengal uptake-excretion test for function using external gamma ray scintillation counting techniques. J Lab Clin Med 45:665–678
Wu RK, Siegel JA, Rattner Z, Malmud LS (1984) Tc-99m HIDA dosimetry in patients with various hepatic disorders. J Nucl Med 25:905–912